bpc-157 dosage and cycle length Guide: Protocols & Safety 2026 Regeneration or Risk? A Narrative
Description
The reduced caloric intake on tirzepatide compounds the problem
Follow-up Repeat broad and inflammation markers after 6-12 weeks if symptoms change or the protocol continues
144 UddinG
Dosing is individualized based on body weight, injury severity, and response, not a onesizefitsall schedule
It is expressed as total blend mass per dose (both peptides combined, since they share the vial)
Smaller syringes offer even more precision for lower doses
